1. Inhibition of TLR4/MAPKs Pathway Contributes to the Protection of Salvianolic Acid A Against Lipotoxicity-Induced Myocardial Damage in Cardiomyocytes and Obese Mice
   Zhen Yang et al, 2021, Frontiers in Pharmacology CrossRef
2. Role and regulation of FOXO3a: new insights into breast cancer therapy
   Wenqiu Mei et al, 2024, Frontiers in Pharmacology CrossRef
3. Curcumin Conjugated Gold Nanoclusters as Perspective Therapeutics for Diabetic Cardiomyopathy
   Dong-zhuo Wei et al, 2021, Frontiers in Chemistry CrossRef
4. Puerarin inhibits NHE1 activity by interfering with the p38 pathway and attenuates mitochondrial damage induced by myocardial calcium overload in heart failure rats
   Guopin Pan et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef
5. Advancements and Challenges of Nanostructured Lipid Carriers for Wound Healing Applications
   Nasrul Wathoni et al, 2024, International Journal of Nanomedicine CrossRef
6. Citronellal improves endothelial dysfunction by affecting the stability of the GCH1 protein
   Yaqi Guo et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef
7. Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases
   Mahvash Hesari et al, 2021, International Journal of Nanomedicine CrossRef
8. Natural AMPK Activators in Cardiovascular Disease Prevention
   Reza Heidary Moghaddam et al, 2022, Frontiers in Pharmacology CrossRef
9. A Mechanistic Review on Therapeutic Potential of Medicinal Plants and their Pharmacologically Active Molecules for Targeting Metabolic Syndrome
   Vinod Kumar Gauttam et al, 2024, Current Pharmaceutical Design CrossRef
10. Role of polyphenolic compounds and their nanoformulations: a comprehensive review on cross-talk between chronic kidney and cardiovascular diseases
    Ankita Rajput et al, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef